Keisuke Kosai
Impact in
- Biotechnology top 10%
- Cancer Research and Treatments
- Genetics top 10%
- Virus-based gene therapy research
Papers in
-
- DNA Repair Mechanisms 1
- Ubiquitin and proteasome pathways 1
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Milton J. Finegold (4 shared papers)Savio L.C. Woo (3 shared papers)S H Chen (2 shared papers)Yibin Wang (1 shared paper)Stephen S. Rich (1 shared paper)Charles F. Contant (1 shared paper)Bo Xu (1 shared paper)Yuki Ono (6 shared papers)
- Journals
- Annals of Surgical Oncology (4 papers)Cancer Science (2 papers)Anticancer Research (2 papers)Proceedings of the National Academy of Sciences (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Keisuke Kosai
18 papers receiving 538 citations
Peers
Comparison fields: 5 of 51
- Biotechnology 90
- Genetics 276
- Oncology 174
- Immunology 119
- Hepatology 25
Countries citing papers authored by Keisuke Kosai
This map shows the geographic impact of Keisuke Kosai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Kosai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Kosai more than expected).
Fields of papers citing papers by Keisuke Kosai
This network shows the impact of papers produced by Keisuke Kosai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Kosai. The network helps show where Keisuke Kosai may publish in the future.
Co-authors
The 25 scholars most cited alongside Keisuke Kosai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 192 | |
| 2 | Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. | 1996 | 109 |
| 3 | Gene therapy for hepatocellular carcinoma: long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vivo. | 1996 | 50 |
| 4 | 2020 | 30 | |
| 5 | 2003 | 29 | |
| 6 | Adenoviral-mediated suicide gene therapy for hepatic metastases of breast cancer. | 1997 | 27 |
| 7 | 2021 | 24 | |
| 8 | 2019 | 22 | |
| 9 | 2021 | 22 | |
| 10 | Infantile cholestasis due to cytomegalovirus infection of the liver. A possible cause of paucity of interlobular bile ducts. | 1993 | 15 |
| 11 | 2022 | 7 | |
| 12 | 2020 | 7 | |
| 13 | 2023 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2021 | 2 | |
| 18 | 2020 | 2 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Keisuke Kosai
Keisuke Kosai is a scholar working on Molecular Biology, Oncology, Biotechnology, Genetics and Surgery, having authored 24 papers that have together received 555 indexed citations. Recurring topics across this work include Cancer Research and Treatments (5 papers), Virus-based gene therapy research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Animal Genetics and Reproduction (2 papers), Immunotherapy and Immune Responses (2 papers), DNA Repair Mechanisms (1 paper), Ubiquitin and proteasome pathways (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Biotechnology (90 citations), Genetics (276 citations), Oncology (174 citations), Immunology (119 citations) and Hepatology (25 citations). Keisuke Kosai has collaborated with scholars based in Japan and United States. Frequent co-authors include Milton J. Finegold, Savio L.C. Woo, S H Chen, Yibin Wang, Stephen S. Rich, Charles F. Contant, Bo Xu, Yuki Ono, Yuka Oku and S L Woo. Their work appears in journals such as Annals of Surgical Oncology, Cancer Science, Anticancer Research, Proceedings of the National Academy of Sciences and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.